Evidence-based review of moxifloxacin

Int Ophthalmol Clin. 2006 Fall;46(4):61-72. doi: 10.1097/01.iio.0000212139.62428.e6.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / pharmacokinetics
  • Anti-Infective Agents / therapeutic use*
  • Aza Compounds / administration & dosage
  • Aza Compounds / pharmacokinetics
  • Aza Compounds / therapeutic use*
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / metabolism
  • Fluoroquinolones
  • Humans
  • Moxifloxacin
  • Ophthalmic Solutions
  • Quinolines / administration & dosage
  • Quinolines / pharmacokinetics
  • Quinolines / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Ophthalmic Solutions
  • Quinolines
  • Moxifloxacin